赛伦生物
(688163)
| 流通市值：26.72亿 | | | 总市值：26.72亿 |
| 流通股本：1.08亿 | | | 总股本：1.08亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 133,341,233.87 | 350,924,252.18 | 182,107,137.22 | 210,364,165.68 |
| 交易性金融资产 | 611,868,602.74 | 449,001,068.49 | 641,207,523.29 | 641,503,178.08 |
| 应收票据及应收账款 | 98,582,846.11 | 50,218,685.97 | 36,678,957.69 | 57,985,723.41 |
| 其中：应收票据 | - | 1,015,200 | - | - |
| 应收账款 | 98,582,846.11 | 49,203,485.97 | 36,678,957.69 | 57,985,723.41 |
| 预付款项 | 128,500 | 1,917,505 | 488,112 | 11,786,087.54 |
| 其他应收款合计 | 978,192.93 | 909,956.45 | 794,640.4 | 1,773,988.6 |
| 存货 | 42,405,191.16 | 47,473,661.57 | 43,275,462.94 | 36,749,332.97 |
| 其他流动资产 | 20,597,899.56 | 11,817,428.19 | 11,811,112.16 | 7,977,277.67 |
| 流动资产合计 | 907,902,466.37 | 912,262,557.85 | 916,362,945.7 | 968,139,753.95 |
| 非流动资产: | | | | |
| 长期股权投资 | - | - | - | 14,289,991.57 |
| 固定资产 | 104,488,670.43 | 106,482,025.18 | 108,979,777.03 | 104,210,591.51 |
| 在建工程 | 63,653,512.88 | 47,439,075.69 | 41,840,485.62 | 17,358,536.87 |
| 生产性生物资产 | 2,996,024.52 | 3,122,436.95 | 2,891,422.12 | 3,945,275.91 |
| 使用权资产 | 3,474,073.39 | 3,553,029.58 | 3,631,985.77 | 3,710,941.96 |
| 无形资产 | 22,862,317.28 | 22,842,706.52 | 23,032,095.77 | 23,221,485.02 |
| 长期待摊费用 | 514,677.63 | 574,664.37 | 634,651.11 | 694,637.85 |
| 递延所得税资产 | 8,541,275.49 | 8,017,978.31 | 7,998,184.1 | 9,890,783.74 |
| 其他非流动资产 | 21,094,954.85 | 11,722,500 | 14,662,409.7 | 22,500 |
| 非流动资产合计 | 227,625,506.47 | 203,754,416.6 | 203,671,011.22 | 177,344,744.43 |
| 资产总计 | 1,135,527,972.84 | 1,116,016,974.45 | 1,120,033,956.92 | 1,145,484,498.38 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 1,888,452.95 | 2,520,597.86 | 1,311,620.5 | 2,017,615.13 |
| 应付账款 | 1,888,452.95 | 2,520,597.86 | 1,311,620.5 | 2,017,615.13 |
| 合同负债 | 3,729,443.79 | 1,967,380.8 | 2,204,866.2 | 2,394,955.64 |
| 应付职工薪酬 | 4,873,189.22 | 1,733,231.28 | 8,138,301.13 | 4,109,467.84 |
| 应交税费 | 7,911,037.06 | 1,954,014.62 | 1,114,122.04 | 6,174,998.94 |
| 其他应付款合计 | 5,116,942.53 | 3,641,263.58 | 6,493,691.05 | 6,743,457.16 |
| 应付股利 | 21,700 | 19,700 | 19,700 | 19,700 |
| 一年内到期的非流动负债 | 309,157.83 | 296,316.87 | 293,447.16 | 287,817.84 |
| 其他流动负债 | 155,744.64 | 59,021.42 | 66,146 | 71,848.67 |
| 流动负债合计 | 23,983,968.02 | 12,171,826.43 | 19,622,194.08 | 21,800,161.22 |
| 非流动负债: | | | | |
| 租赁负债 | 3,842,144.35 | 4,042,306 | 4,003,157.65 | 4,194,713.95 |
| 递延所得税负债 | 868,518.35 | 907,996.44 | 907,996.44 | 5,331,876.99 |
| 非流动负债合计 | 4,710,662.7 | 4,950,302.44 | 4,911,154.09 | 9,526,590.94 |
| 负债合计 | 28,694,630.72 | 17,122,128.87 | 24,533,348.17 | 31,326,752.16 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 108,220,000 | 108,220,000 | 108,220,000 | 108,220,000 |
| 资本公积 | 878,087,814.86 | 878,087,814.86 | 878,087,814.86 | 878,087,814.86 |
| 盈余公积 | 51,677,171.45 | 51,677,171.45 | 51,677,171.45 | 45,817,944.54 |
| 未分配利润 | 68,848,355.81 | 60,909,859.27 | 57,515,622.44 | 82,031,986.82 |
| 归属于母公司股东权益合计 | 1,106,833,342.12 | 1,098,894,845.58 | 1,095,500,608.75 | 1,114,157,746.22 |
| 股东权益合计 | 1,106,833,342.12 | 1,098,894,845.58 | 1,095,500,608.75 | 1,114,157,746.22 |
| 负债和股东权益合计 | 1,135,527,972.84 | 1,116,016,974.45 | 1,120,033,956.92 | 1,145,484,498.38 |
| 公告日期 | 2025-08-26 | 2025-04-26 | 2025-04-26 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |